Mechanism of viral hepatitis-mediated hepatocarcinogenesis
Mechanism of viral hepatitis-mediated hepatocarcinogenesis
批准号:
7592554
负责人:
XIN WEI WANG
金额:
$30.88万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Animal ModelAntigen PresentationAntiviral ResponseB-LymphocytesBinding ProteinsCell DeathCentrosomeChromosomal InstabilityChronicComplexDevelopmentDisruptionDockingGene ExpressionGenesGenomic InstabilityGoalsHepatitisHepatitis B VirusHepatitis CHepatitis C virusHepatocarcinogenesisHepatocyteHomeostasisHumanImmunityInflammationLiverMediatingMitosisMitotic spindleMolecularMolecular ProfilingNatural regenerationNuclear ExportOncogenicPathogenesisPathway interactionsPatientsPeptidylprolyl IsomerasePilot ProjectsPlayPrimary carcinoma of the liver cellsProteinsResearchRoleRunningSignal TransductionTP53 geneTissuesTumor-DerivedVariantViral PhysiologyViral ProteinsViral hepatitisViruscarcinogenesismetaplastic cell transformationmutantnovelnucleocytoplasmic transportnucleophosminpreventran-binding protein 1toolvirus core
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our previous results indicate that HBx contains a functional nuclear export signal motif that utilizes the Ran/Crm1 complex, a component essential in nucleocytoplasmic transport of many cellular and viral proteins. We demonstrated that HBx not only uses but also disrupts Ran/Crm1-dependent activities, presumably to prevent a host antiviral response. This finding implicates the Ran/Crm1 complex in the molecular pathogenesis of HBV. Recently, we uncovered a new role of the Ran/Crm1 complex in regulating cellular proteins that control centrosome duplication and mitotic spindle assembly. We revealed nucleophosmin as a novel substrate for Ran/Crm1 to negatively regulate unnecessary centrosome duplication. In addition, we demonstrated a HBV/HBx-dependent activation of RanBP1, a Ran-binding protein that is known to destabilize the Ran/Crm1 complex. Elevated RanBP1 is also observed in HBV-positive liver tissues and in HCC. Increased expression of RanBP1 leads to multipolar spindles and abnormal mitoses. Thus, the combined effects of HBV/HBx contribute to chromosome instability. These findings led us to generate a new hypothesis in which the Ran/Crm1 complex serves as the centrosome duplication checkpoint by providing a loading dock mechanism that controls cellular homeostasis, and the disruption of this complex may result in genomic instability, which may be an early step in viral hepatitis-mediated hepatocarcinogenesis. In addition to HBx, recently we have completed a pilot study by determining HCV core-related gene expression profiles in B lymphocytes. We found that HCV core may evict immunity by selectively suppressing genes involved in antigen presentation. These studies are useful in dissecting viral activities that are essential in hepatocarcinogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AUTOMATIC PHOSPHORUS MAGNETIC RESONANCE SPECTROCOPY DATA QUANTIFICATION
-
批准号:8171165
-
项目类别:
-
资助金额:$0.61万
-
财政年份:2010
-
负责人:XIN WEI WANG
-
依托单位:
AUTOMATIC PHOSPHORUS MAGNETIC RESONANCE SPECTROCOPY DATA QUANTIFICATION
-
批准号:7955804
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2009
-
负责人:XIN WEI WANG
-
依托单位:
AUTOMATIC PHOSPHORUS MAGNETIC RESONANCE SPECTROCOPY DATA QUANTIFICATION
-
批准号:7724539
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2008
-
负责人:XIN WEI WANG
-
依托单位:
Mechanism of viral hepatitis-mediated liver carcinogenes
-
批准号:6558973
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Mechanisms of G2/M cell cycle checkpoint controls
-
批准号:6763835
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Mechanism of viral hepatitis-mediated hepatocarcinogenes
-
批准号:6950164
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Molecular profiling of human hepatocellular cancer
-
批准号:6951273
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Mechanism of viral hepatitis-mediated hepatocarcinogenes
-
批准号:7048109
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Molecular profiling of hepatocellular carcinoma
-
批准号:6763500
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
GENE EXPRESSION PROFILE IN HEPATOCELLULAR CARCINOMA
-
批准号:6289377
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
MECHANISM OF VIRAL HEPATITIS-MEDIATED LIVER CARCINOGENES
-
批准号:6435175
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Molecular profiling of hepatocellular carcinoma
-
批准号:6559191
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Mechanism of viral hepatitis-mediated hepatocarcinogenes
-
批准号:7337928
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Molecular profiling of human hepatocellular cancer
-
批准号:7338447
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Mechanism of viral hepatitis-mediated hepatocarcinogenesis
-
批准号:7732902
-
项目类别:
-
资助金额:$32.7万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Molecular profiling of human hepatocellular cancer
-
批准号:7291702
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Molecular signatures for liver cancer diagnosis and treatment stratification
-
批准号:7732996
-
项目类别:
-
资助金额:$49.04万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Mechanism of viral hepatitis-mediated hepatocarcinogenes
-
批准号:6761638
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
Molecular profiling of human hepatocellular cancer
-
批准号:7592660
-
项目类别:
-
资助金额:$134.52万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
MECHANISMS OF G2 / M CELL CYCLE CHECKPOINT CONTROLS
-
批准号:6430331
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:XIN WEI WANG
-
依托单位:
海外基金